A preclinical analysis of T helper 1 cells shows that shifting their metabolism from glycolysis to #oxphos# curtails their role in inflammatory bowel disease and identifies a potential therapeutic target for these conditions. @MayoClinic
A preclinical @SciSignal analysis of T helper 1 cells shows that shifting their metabolism from glycolysis to #oxphos# curtails their role in inflammatory bowel disease and identifies a potential therapeutic target for these conditions.